Literature DB >> 23225158

Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma.

Peng Zhou1, Lie-Lin Wu, Ke-Min Wu, Wei Jiang, Jin-Dong Li, Le-du Zhou, Xin-Ying Li, Shi Chang, Yun Huang, Hui Tan, Ge-Wen Zhang, Feng He, Zhi-Ming Wang.   

Abstract

The multiple myeloma SET domain (MMSET) involved in the t(4;14)(p16;q32) chromosomal translocation encodes a histone lysine methyltransferase. High expression of MMSET is common translocation in multiple myeloma (MM) and is associated with the worst prognosis. Recent studies have shown that overexpression of MMSET is significant in other tumor types compared to their normal tissues. However, little is known about its role in hepatocellular carcinoma (HCC). In these study we investigate the expression of MMSET in HCC and to make correlations with clinicopathologic features. Twenty-eight pairs of HCC and adjacent non-tumor tissues, and eight normal liver tissues were collected for MMSET detection by western blotting and real time-PCR analysis. Immunohistochemistry was used to determine the expression of MMSET in HCC and adjacent non-tumor tissues from 103 patients. Overexpression of MMSET was significantly associated with Edmondson stage, vascular invasion. Moreover, Kaplan-Meier curves showed that MMSET upregulated was associated with shorter overall survival and disease-free survival in HCC patient. In conclusion, our study demonstrates for the first time that overexpression of MMSET is an independent prognostic factor and is correlated with poor survival in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225158     DOI: 10.1007/s12253-012-9583-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

1.  Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.

Authors:  Heidi Rye Hudlebusch; Kim Theilgaard-Mönch; Marianne Lodahl; Hans Erik Johnsen; Thomas Rasmussen
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

2.  The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.

Authors:  Eva Martinez-Garcia; Relja Popovic; Dong-Joon Min; Steve M M Sweet; Paul M Thomas; Leonid Zamdborg; Aaron Heffner; Christine Will; Laurence Lamy; Louis M Staudt; David L Levens; Neil L Kelleher; Jonathan D Licht
Journal:  Blood       Date:  2010-10-25       Impact factor: 22.113

Review 3.  Sorafenib for treatment of hepatocellular carcinoma: a systematic review.

Authors:  Bingru Xie; David H Wang; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

Review 4.  Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma.

Authors:  Jonathan J Keats; Tony Reiman; Andrew R Belch; Linda M Pilarski
Journal:  Leuk Lymphoma       Date:  2006-11

5.  Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.

Authors:  Gouji Toyokawa; Hyun-Soo Cho; Ken Masuda; Yuka Yamane; Masanori Yoshimatsu; Shinya Hayami; Masashi Takawa; Yukiko Iwai; Yataro Daigo; Eiju Tsuchiya; Tatsuhiko Tsunoda; Helen I Field; John D Kelly; David E Neal; Yoshihiko Maehara; Bruce Aj Ponder; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

6.  The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.

Authors:  Jotin Marango; Manabu Shimoyama; Hitomi Nishio; Julia A Meyer; Dong-Joon Min; Andres Sirulnik; Yolanda Martinez-Martinez; Marta Chesi; P Leif Bergsagel; Ming-Ming Zhou; Samuel Waxman; Boris A Leibovitch; Martin J Walsh; Jonathan D Licht
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

7.  The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

Authors:  M Chesi; E Nardini; R S Lim; K D Smith; W M Kuehl; P L Bergsagel
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

8.  Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity.

Authors:  Ji-Young Kim; Hae Jin Kee; Nak-Won Choe; Sung-Mi Kim; Gwang-Hyeon Eom; Hee Jo Baek; Hyun Kook; Hoon Kook; Sang-Beom Seo
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

9.  In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.

Authors:  Jonathan J Keats; Tony Reiman; Christopher A Maxwell; Brian J Taylor; Loree M Larratt; Michael J Mant; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

Review 10.  Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.

Authors:  Erzsébet Szabó; Csilla Páska; Pál Kaposi Novák; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

View more
  11 in total

1.  Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC).

Authors:  Si-Yuan Tian; Shou-Hua Chen; Bing-Feng Shao; Hong-Yu Cai; Yuan Zhou; Yi-Long Zhou; Ai-Bing Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Expression of SGTA correlates with prognosis and tumor cell proliferation in human hepatocellular carcinoma.

Authors:  Cuihua Lu; Guoliang Liu; Xiaopeng Cui; Jing Zhang; Lixian Wei; Yingying Wang; Xiaojing Yang; Yanhua Liu; Xia Cong; Liting Lv; Runzhou Ni; Xiaodong Huang
Journal:  Pathol Oncol Res       Date:  2013-07-10       Impact factor: 3.201

3.  Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.

Authors:  Zegui Tu; Xiancheng Chen; Tian Tian; Guo Chen; Meijuan Huang
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

4.  WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.

Authors:  Jingjing Dai; Longfeng Jiang; Lei Qiu; Yuyun Shao; Ping Shi; Jun Li
Journal:  Onco Targets Ther       Date:  2020-07-20       Impact factor: 4.147

5.  An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer.

Authors:  Zhen Yang; Allison Jones; Martin Widschwendter; Andrew E Teschendorff
Journal:  Genome Biol       Date:  2015-07-14       Impact factor: 13.583

6.  Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.

Authors:  Relja Popovic; Eva Martinez-Garcia; Eugenia G Giannopoulou; Quanwei Zhang; Qingyang Zhang; Teresa Ezponda; Mrinal Y Shah; Yupeng Zheng; Christine M Will; Eliza C Small; Youjia Hua; Marinka Bulic; Yanwen Jiang; Matteo Carrara; Raffaele A Calogero; William L Kath; Neil L Kelleher; Ji-Ping Wang; Olivier Elemento; Jonathan D Licht
Journal:  PLoS Genet       Date:  2014-09-04       Impact factor: 5.917

7.  Downregulation of MMSET impairs breast cancer proliferation and metastasis through inhibiting Wnt/β-catenin signaling.

Authors:  Xiaohui Zhao; Tian Xie; Wenhui Zhao; Wanhua Cai; Xiaobo Su
Journal:  Onco Targets Ther       Date:  2019-03-14       Impact factor: 4.147

8.  Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.

Authors:  J Wei; C Costa; J Shen; L Yu; J J Sanchez; X Qian; X Sun; Z Zou; A Gimenez-Capitan; G Yue; W Guan; R Rosell; B Liu
Journal:  Br J Cancer       Date:  2014-05-08       Impact factor: 7.640

9.  NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.

Authors:  Verónica García-Carpizo; Jacinto Sarmentero; Bomie Han; Osvaldo Graña; Sergio Ruiz-Llorente; David G Pisano; Manuel Serrano; Harold B Brooks; Robert M Campbell; Maria J Barrero
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

10.  Clinical significance and biological roles of small nucleolar RNAs in hepatocellular carcinoma.

Authors:  Dilip Baral; Long Wu; Gaurav Katwal; Xiong Yan; Yanfeng Wang; Qifa Ye
Journal:  Biomed Rep       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.